Jazz Pharma, Concert Pharma Report JZP-386 Program Update By: Benzinga via Benzinga December 09, 2014 at 08:30 AM EST Jazz Pharmaceuticals plc (NASDAQ: JAZZ) and Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today announced that Phase 1 clinical data ... Read More >> Related Stocks: Concert Pharmaceutic Jazz Pharma Plc